MedTrace Logo

Metformin for the Treatment of Diabetes in Pregnancy

NCT00414245 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2006-12-21

No results posted yet for this study

Summary

The purpose of this study is to determine whether metformin is effective and safe in the treatment of diabetes in pregnancy.

Conditions

  • Gestational Diabetes
  • Diabetes Mellitus Type 2

Interventions

DRUG

metformin

Sponsors & Collaborators

  • Ben-Gurion University of the Negev

    collaborator OTHER

  • Soroka University Medical Center

    lead OTHER

Principal Investigators

  • Boaz Sheizaf, MD · division of obstetrics and gynecology, soroka university medical center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00414245 on ClinicalTrials.gov